Correction: Posttreatment pulse rate reduction and not baseline pulse rate as an indicator of blood pressure response to nebivolol: a subanalysis from the real-world BENEFIT-KOREA study.
- DOI
- 10.5646/ch.2025.31.e24
- Published
- 2025
- Container
- Clinical hypertension
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.5646/ch.2025.31.e24,
title = {Correction: Posttreatment pulse rate reduction and not baseline pulse rate as an indicator of blood pressure response to nebivolol: a subanalysis from the real-world BENEFIT-KOREA study.},
author = {Shin J and Cha DH and Bae WH and Jung IH and Hong SP and Kim SH and Do JY and Hwang WM and Koh YY and Mancia G and Manolis AJ and Lee M},
year = {2025},
journal = {Clinical hypertension},
doi = {10.5646/ch.2025.31.e24},
url = {https://doi.org/10.5646/ch.2025.31.e24}
}RIS
TY - JOUR TI - Correction: Posttreatment pulse rate reduction and not baseline pulse rate as an indicator of blood pressure response to nebivolol: a subanalysis from the real-world BENEFIT-KOREA study. AU - Shin J AU - Cha DH AU - Bae WH AU - Jung IH AU - Hong SP AU - Kim SH AU - Do JY AU - Hwang WM AU - Koh YY AU - Mancia G AU - Manolis AJ AU - Lee M PY - 2025 JO - Clinical hypertension DO - 10.5646/ch.2025.31.e24 UR - https://doi.org/10.5646/ch.2025.31.e24 ER -
APA
J, S., DH, C., WH, B., IH, J., SP, H., SH, K., JY, D., WM, H., YY, K., G, M., AJ, M., & M, L. (2025). Correction: Posttreatment pulse rate reduction and not baseline pulse rate as an indicator of blood pressure response to nebivolol: a subanalysis from the real-world BENEFIT-KOREA study.. Clinical hypertension. https://doi.org/10.5646/ch.2025.31.e24
Source records
- pubmed · retrieved 2026-09-26T02:34:09.716Z
- europe-pmc · retrieved 2026-09-26T02:34:09.728Z